Live Breaking News & Updates on Nct03449381

Stay updated with breaking news from Nct03449381. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BI 907828 Demonstrates Early Efficacy, Safety in MDM2-amplified Dedifferentiated Liposarcoma

The oral MDM2/p53 antagonist BI 907828 elicited preliminary antitumor activity and had a manageable safety profile in patients with MDM2-amplified dedifferentiated liposarcoma. ....

Region Flamande , Patrick Schoffski , Acta Biochim Biophys , University Hospitals Leuven , Boehringer Ingelheim , Rare Cancers Congress , Oncology At Leuven Cancer Institute , Rare Cancers , General Medical Oncology , Leuven Cancer Institute , Sartar Therapeutics , Ellipses Pharma , Merck Healthcare , Biochim Biophys Sin , Sarcomas Tgct , 2023 Esmo Sarcoma And Rare Cancers Congress , Dedifferentiated Liposarcoma ,